Literature DB >> 15246373

Availability of N-isopropyl-p-[125I]iodoamphetamine (IMP) as a practical cerebral blood flow (CBF) indicator in rats.

Takashi Temma1, Yasuhiro Magata, Takahiro Mukai, Haruhiro Kitano, Junji Konishi, Hideo Saji.   

Abstract

Since a very complicated technique is necessary to measure cerebral blood flow (CBF) with [14C]iodoantipyrine in small animals, a practical and easy method is needed. In this paper, the differential uptake ratio (DUR) at 5 min after injection of N-isopropyl-p-[125I]iodoamphetamine (IMP) was estimated as an index of CBF in normal rats and compared with the quantitative CBF value measured using [15O]H2O and dynamic PET scan. A good correlation between the two values was obtained. The results indicate that DUR of [125I]IMP at 5 min after injection in rats is a useful and practical indicator of CBF since neither arterial blood sampling nor metabolite correction is necessary. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246373     DOI: 10.1016/j.nucmedbio.2004.02.008

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  3 in total

1.  Conscious rat PET imaging with soft immobilization for quantitation of brain functions: comprehensive assessment of anesthesia effects on cerebral blood flow and metabolism.

Authors:  Chie Suzuki; Mutsumi Kosugi; Yasuhiro Magata
Journal:  EJNMMI Res       Date:  2021-05-08       Impact factor: 3.138

2.  A novel intravital method to evaluate cerebral vasospasm in rat models of subarachnoid hemorrhage: a study with synchrotron radiation angiography.

Authors:  Jun Cai; Yuhao Sun; Falei Yuan; Lujia Chen; Chuan He; Yuhai Bao; Zuoquan Chen; Meiqing Lou; Weiliang Xia; Guo-Yuan Yang; Feng Ling
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

3.  Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography.

Authors:  Thomas Wanek; Kerstin Römermann; Severin Mairinger; Johann Stanek; Michael Sauberer; Thomas Filip; Alexander Traxl; Claudia Kuntner; Jens Pahnke; Florian Bauer; Thomas Erker; Wolfgang Löscher; Markus Müller; Oliver Langer
Journal:  Mol Pharm       Date:  2015-08-03       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.